Is TNF Pharmaceuticals, Stock a Good Investment?
TNF Pharmaceuticals, Investment Advice | TNFA |
- Examine TNF Pharmaceuticals,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research TNF Pharmaceuticals,'s leadership team and their track record. Good management can help TNF Pharmaceuticals, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact TNF Pharmaceuticals,'s business and its evolving consumer preferences.
- Compare TNF Pharmaceuticals,'s performance and market position to its competitors. Analyze how TNF Pharmaceuticals, is positioned in terms of product offerings, innovation, and market share.
- Check if TNF Pharmaceuticals, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about TNF Pharmaceuticals,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in TNF Pharmaceuticals, stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if TNF Pharmaceuticals, is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine TNF Pharmaceuticals, Stock
Researching TNF Pharmaceuticals,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 40.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TNF Pharmaceuticals, recorded a loss per share of 10.48. The entity last dividend was issued on the 25th of November 2019. The firm had 1:30 split on the 15th of February 2024.
To determine if TNF Pharmaceuticals, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding TNF Pharmaceuticals,'s research are outlined below:
| TNF Pharmaceuticals, had very high historical volatility over the last 90 days | |
| TNF Pharmaceuticals, may become a speculative penny stock | |
| TNF Pharmaceuticals, was previously known as MyMD Pharmaceuticals and was traded on NASDAQ Exchange under the symbol MYMD. | |
| Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TNF Pharmaceuticals, generates negative cash flow from operations | |
| TNF Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in SarcopeniaFrailty Induced by GLP-1 Weight Loss Drugs |
TNF Pharmaceuticals,'s market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.13 M.Market Cap |
|
TNF Pharmaceuticals,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.54) | (0.57) | |
| Return On Capital Employed | (1.33) | (1.26) | |
| Return On Assets | (0.22) | (0.24) | |
| Return On Equity | (0.31) | (0.33) |
Determining TNF Pharmaceuticals,'s profitability involves analyzing its financial statements and using various financial metrics to determine if TNF Pharmaceuticals, is a good buy. For example, gross profit margin measures TNF Pharmaceuticals,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of TNF Pharmaceuticals,'s profitability and make more informed investment decisions.
Please note, the presentation of TNF Pharmaceuticals,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TNF Pharmaceuticals,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TNF Pharmaceuticals,'s management manipulating its earnings.
Evaluate TNF Pharmaceuticals,'s management efficiency
TNF Pharmaceuticals, has return on total asset (ROA) of (0.3243) % which means that it has lost $0.3243 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.9763) %, meaning that it created substantial loss on money invested by shareholders. TNF Pharmaceuticals,'s management efficiency ratios could be used to measure how well TNF Pharmaceuticals, manages its routine affairs as well as how well it operates its assets and liabilities. As of December 23, 2024, Return On Tangible Assets is expected to decline to -0.57. The current year's Return On Capital Employed is expected to grow to -1.26. At present, TNF Pharmaceuticals,'s Total Assets are projected to decrease significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 1.21, whereas Non Current Assets Total are forecasted to decline to about 10.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.28 | 7.87 | |
| Tangible Book Value Per Share | 1.47 | 1.40 | |
| Enterprise Value Over EBITDA | (0.07) | (0.07) | |
| Price Book Value Ratio | 0.23 | 0.24 | |
| Enterprise Value Multiple | (0.07) | (0.07) | |
| Price Fair Value | 0.23 | 0.24 | |
| Enterprise Value | 313.9 K | 329.6 K |
The strategic decisions made by TNF Pharmaceuticals, management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Beta 2.673 |
Basic technical analysis of TNF Stock
As of the 23rd of December, TNF Pharmaceuticals, has the risk adjusted performance of 0.0505, and Coefficient Of Variation of 1910.81. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of TNF Pharmaceuticals,, as well as the relationship between them.Understand TNF Pharmaceuticals,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing TNF Pharmaceuticals,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0505 | |||
| Market Risk Adjusted Performance | (1.70) | |||
| Mean Deviation | 5.94 | |||
| Semi Deviation | 7.17 | |||
| Downside Deviation | 7.41 | |||
| Coefficient Of Variation | 1910.81 | |||
| Standard Deviation | 7.93 | |||
| Variance | 62.96 | |||
| Information Ratio | 0.0483 | |||
| Jensen Alpha | 0.4105 | |||
| Total Risk Alpha | 0.1831 | |||
| Sortino Ratio | 0.0517 | |||
| Treynor Ratio | (1.71) | |||
| Maximum Drawdown | 41.7 | |||
| Value At Risk | (13.07) | |||
| Potential Upside | 13.71 | |||
| Downside Variance | 54.92 | |||
| Semi Variance | 51.36 | |||
| Expected Short fall | (6.95) | |||
| Skewness | 0.0279 | |||
| Kurtosis | 0.8418 |
| Risk Adjusted Performance | 0.0505 | |||
| Market Risk Adjusted Performance | (1.70) | |||
| Mean Deviation | 5.94 | |||
| Semi Deviation | 7.17 | |||
| Downside Deviation | 7.41 | |||
| Coefficient Of Variation | 1910.81 | |||
| Standard Deviation | 7.93 | |||
| Variance | 62.96 | |||
| Information Ratio | 0.0483 | |||
| Jensen Alpha | 0.4105 | |||
| Total Risk Alpha | 0.1831 | |||
| Sortino Ratio | 0.0517 | |||
| Treynor Ratio | (1.71) | |||
| Maximum Drawdown | 41.7 | |||
| Value At Risk | (13.07) | |||
| Potential Upside | 13.71 | |||
| Downside Variance | 54.92 | |||
| Semi Variance | 51.36 | |||
| Expected Short fall | (6.95) | |||
| Skewness | 0.0279 | |||
| Kurtosis | 0.8418 |
Consider TNF Pharmaceuticals,'s intraday indicators
TNF Pharmaceuticals, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TNF Pharmaceuticals, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
TNF Pharmaceuticals, time-series forecasting models is one of many TNF Pharmaceuticals,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TNF Pharmaceuticals,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
TNF Stock media impact
Far too much social signal, news, headlines, and media speculation about TNF Pharmaceuticals, that are available to investors today. That information is available publicly through TNF media outlets and privately through word of mouth or via TNF internal channels. However, regardless of the origin, that massive amount of TNF data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of TNF Pharmaceuticals, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of TNF Pharmaceuticals, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to TNF Pharmaceuticals,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive TNF Pharmaceuticals, alpha.
When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.48) | Return On Assets (0.32) | Return On Equity (2.98) |
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between TNF Pharmaceuticals,'s value and its price, as these two are different measures arrived at by various means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.